Overcoming intra-tumoral heterogeneity for biomarker discovery in the high-grade serous ovarian cancer proteome
Details
Publication Year 2025-06-11,Volume 9,Issue #1,Page 172
Journal Title
NPJ Precision Oncology
Publication Type
Research article
Abstract
Improved biomarkers of treatment response are needed for patients with high-grade serous ovarian cancer (HGSC). A challenge is substantial anatomical site-to-site variation in expression. We completed data-independent acquisition-mass spectrometry (DIA-MS) analysis of 404 fresh frozen and 78 formalin-fixed, paraffin-embedded HGSC tissue samples from the ovary (adnexal) and a common secondary site (omentum) in 11 patients. This was compared with mutation testing, gene expression, and whole-genome copy number profiling. Proteins with relatively stable intra- and variable inter-individual expression (n = 1651), included a 52-protein module reflecting interferon-mediated tissue inflammation, indicative of a cGAS-STING pathway cytosolic double-stranded (ds) DNA response. The dsDNA sensing/inflammation score was higher in the omentum compared with the ovary. Ovarian HGSC samples showed marked inter-individual differences in inflammatory and immune responses to DNA damage. Stable discriminative features of the HGSC proteome, a prerequisite for clinical predictive biomarkers, are detectable in ovary (adnexal) tissue samples.
Publisher
Springer Nature
Department(s)
Laboratory Research
Open Access at Publisher's Site
https://doi.org/10.1038/s41698-025-00911-y
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2025-07-31 04:18:37
Last Modified: 2025-07-31 04:18:59
An error has occurred. This application may no longer respond until reloaded. Reload 🗙